N/A
Completed N=60
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
Enlarged Lymph Nodes (Excluding Infective)
Source: ClinicalTrials.gov NCT03657849 ↗
Enrolled (actual)
60
Serious AEs
5.0%
Results posted
Mar 2023
Primary outcomePrimary: Diagnostic Yield — 69; 68; 57; 57 lymph nodes
Summary
This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Diagnostic Yield |
126; 125 | — |
Eligibility Criteria
Inclusion Criteria
- Age 18 years or older
- Able to provide informed consent
- Referred for EBUS TBNA sampling at Regions Hospital
Exclusion Criteria
- On therapeutic warfarin, Plavix, or ticagrelor in the past 5 days
- INR>1.8 or platelets <50K
Data sourced from ClinicalTrials.gov (NCT03657849). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.